Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, March 15 '25)

 


    Biochemistry (Mosc)

  1. FILIPPOVA TA, Masamrekh RA, Farafonova TE, Khudoklinova YY, et al
    Determination of SARS-CoV-2 Main Protease (M(pro)) Activity Based on Electrooxidation of Tyrosine Residue of a Model Peptide.
    Biochemistry (Mosc). 2025;90:120-131.
    PubMed         Abstract available


    BMC Pediatr

  2. JAYARATNE K, Illangasinghe P, Wanniarachchi S, Hettiarachchi D, et al
    Epidemic profile of COVID-19 child deaths in Sri Lanka: a retrospective nationwide analysis.
    BMC Pediatr. 2025;25:174.
    PubMed         Abstract available


    Cell

  3. XING L, Liu Z, Wang X, Liu Q, et al
    Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target.
    Cell. 2025;188:1297-1314.
    PubMed         Abstract available


    J Epidemiol Community Health

  4. COSTE M, Prah JJ
    Applying the health capability profile: an analytical study of leading causes of death in the USA and of pressing public health issues.
    J Epidemiol Community Health. 2025;79:302-310.
    PubMed         Abstract available

  5. AGARWAL G, Keshavarz H, Angeles R, Pirrie M, et al
    SARS-CoV-2 testing, test positivity and vaccination in social housing residents compared with the general population: a retrospective population-based cohort study.
    J Epidemiol Community Health. 2025;79:233-238.
    PubMed         Abstract available

  6. JIN H, Lee WJ, Maupin D, Lee JO, et al
    Within-person relationship between employment insecurity and mental health: a longitudinal analysis of the Understanding America Study.
    J Epidemiol Community Health. 2025;79:265-271.
    PubMed         Abstract available


    J Immunol

  7. GROVENSTEIN P, Bhatnagar N, Kim KH, Pal SS, et al
    Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered.
    J Immunol. 2025;214:104-114.
    PubMed         Abstract available

  8. QIAO P, Yue C, Peng W, Liu K, et al
    Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2.
    J Immunol. 2025;214:115-129.
    PubMed         Abstract available

  9. WANG M, Liu C, Fan Q, Sun Y, et al
    Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies.
    J Immunol. 2025;214:278-289.
    PubMed         Abstract available


    J Infect Dis

  10. VILLALOBOS RODRIGUEZ AP, Wellington Perkins I, Moosavi S, de la Garza A, et al
    Pandemic Preparedness: Analyzing National Plans for Respiratory Pathogen Pandemics in the Americas Region.
    J Infect Dis. 2025;231.
    PubMed         Abstract available

  11. REDONDO-BRAVO L, Zureick K, Voto C, Molina Avendano X, et al
    A Comparative Analysis of Universal and Sentinel Surveillance Data for Coronavirus Disease 2019: Insights From Argentina, Chile, and Mexico (2020-2022).
    J Infect Dis. 2025;231.
    PubMed         Abstract available

  12. RODRIGUEZ A, Couto P, Acevedo A, Herrera BA, et al
    Strengthening the Surveillance and Response to Public Health Events With a One Health Approach: A Perspective From 12 Countries in Latin America and the Caribbean.
    J Infect Dis. 2025;231.
    PubMed         Abstract available


    JAMA

  13. MAIA IS, Kawano-Dourado L, Tramujas L, de Oliveira NE, et al
    High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial.
    JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26244.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  14. ZHU S, Harriman K, Liu C, Kraushaar V, et al
    Human Cases of Highly Pathogenic Avian Influenza A(H5N1) - California, September-December 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:127-133.
    PubMed         Abstract available


    PLoS Comput Biol

  15. AMARAL AVR, Wolffram D, Moraga P, Bracher J, et al
    Post-processing and weighted combination of infectious disease nowcasts.
    PLoS Comput Biol. 2025;21:e1012836.
    PubMed         Abstract available


    PLoS Med

  16. AHMADI-ABHARI S, Bandosz P, Shipley MJ, Lindbohm JV, et al
    Direct and indirect impacts of the COVID-19 pandemic on life expectancy and person-years of life lost with and without disability: A systematic analysis for 18 European countries, 2020-2022.
    PLoS Med. 2025;22:e1004541.
    PubMed         Abstract available


    PLoS One

  17. ADAMU H, Lawal S, Bawa IA, Sani AM, et al
    Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria.
    PLoS One. 2025;20:e0277585.
    PubMed         Abstract available

  18. GONCALVES NV, Leal AL, Guimaraes HMMES, Bernardes AC, et al
    The territorialization of Severe Acute Respiratory Syndrome and its socioeconomic, demographic and public health policy risk factors in Belem, state of Para, Eastern Amazon, Brazil: a cross-sectional and ecological study.
    PLoS One. 2025;20:e0318607.
    PubMed         Abstract available

  19. DEGUCHI Y, Iwasaki S, Uesaka Y, Okawa Y, et al
    Remote work and long-term sickness absence due to mental disorder trends among Japanese workers pre/post COVID-19.
    PLoS One. 2025;20:e0319825.
    PubMed         Abstract available

  20. HTET H, Wichaidit W, Chuaychai A, Sottiyotin T, et al
    Perspectives of stakeholders on barriers to COVID-19 protective behaviors adherence and vaccination among Myanmar migrant workers in southern Thailand: A qualitative study.
    PLoS One. 2025;20:e0317714.
    PubMed         Abstract available

  21. MOHRI P, Koyluoglu YO, Seker ME, Sancak SN, et al
    Medical students' perception of paid E-learning.
    PLoS One. 2025;20:e0317340.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. WANG Q, Xu S, Shen W, Wei Y, et al
    N6-methyladnosine of vRNA facilitates influenza A virus replication by promoting the interaction of vRNA with polymerase proteins.
    Proc Natl Acad Sci U S A. 2025;122:e2411554122.
    PubMed         Abstract available


    Vaccine

  23. KRAMMER F
    Next-generation seasonal influenza virus vaccines need a neuraminidase component.
    Vaccine. 2025;54:126994.
    PubMed        

  24. OTIENO NA, Kalani R, Ayugi J, Nyawanda BO, et al
    Seasonal influenza vaccination in Kenya: What determines healthcare Workers' willingness to accept and recommend vaccination?
    Vaccine. 2025;54:126963.
    PubMed         Abstract available


    Virology

  25. OSPINA-JIMENEZ AF, Gomez AP, Rincon-Monroy MA, Perez DR, et al
    A novel reassorted swine H3N2 influenza virus demonstrates an undetected human-to-swine spillover in Latin America and highlights zoonotic risks.
    Virology. 2025;606:110483.
    PubMed         Abstract available

  26. PAWAR SD, Keng SS, Tare DS, Balakrishnan A, et al
    Evidence of novel reassortment in clade 2.3.4.4b avian influenza H5N1 viruses, India, 2024.
    Virology. 2025;606:110482.
    PubMed         Abstract available

Comments

Popular posts from this blog

#USA, APHIS Confirms {Avian #Influenza #H5N1} #D11 #Genotype in Dairy #Cattle in #Nevada

On January 31, 2025, the USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL) confirmed by whole genome sequence the first detection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b, genotype D1.1 in dairy cattle .  This confirmation was a result of State tracing and investigation, following an initial detection on silo testing under the USDA’s National Milk Testing Strategy (NMTS) in Nevada.  USDA APHIS continues to work with the Nevada Department of Agriculture by conducting additional on-farm investigation, testing, and gathering additional epidemiological information to better understand this detection and limit further disease spread.  This is the first detection of this virus genotype in dairy cattle (all previous detections in dairy cattle have been HPAI H5N1 clade 2.3.4.4b, genotype B3.13 ).  Genotype D1.1 represents the predominant genotype in the North American flyways this past fall an...

#USA, After #Birdflu Detected in Local #Cat, County #Health Officials Say #Pet Owners Should Contact Veterinarian When Their Pets are Sick

Redwood City — State veterinary and health officials have confirmed a case of H5N1 (bird flu) in a domestic stray cat in San Mateo County.  The infection, which is not related to the recent instance of bird flu in a backyard flock , was found in a stray cat in Half Moon Bay that had been taken in by a family .  When it showed symptoms, they took it to Peninsula Humane Society, whose veterinarians examined it and requested testing. Lab results confirmed H5N1.  It is not known how the cat was infected and it was euthanized due to its condition. Cats may be exposed to bird flu by consuming infected bird , being in environments contaminated with the virus and consuming unpasteurized milk from infected cows or raw food. Inside domestic animals, such as cats and dogs, that go outside are also at risk of infection.​​​​​​​ According to the Centers for Disease Control and Prevention, the risk of cats spreading H5N1 to people is extremely low, though it is possible for cats to spre...

#USA, Novel #Influenza A #H5N1 Virus: One Pediatric Case in #California {FluView}

 {Excerpt} One confirmed human infection with influenza A(H5) virus was reported to CDC this week. To date, human-to-human transmission of influenza A(H5) virus has not been identified in the United States. This case was reported by the California Department of Public Health and occurred in a child less than 18 years old with no known contact with influenza A(H5N1) virus-infected animals or humans . The investigation into the source of infection for this case is ongoing , and no human-to-human transmission has been identified. A specimen from the individual was tested at a public health laboratory using the CDC influenza A(H5) assay before being sent to CDC for further testing. The specimen was positive for influenza A(H5) virus using diagnostic RT-PCR at CDC. Additional analysis including genetic sequencing is underway. In response to this detection, additional case investigation and contact monitoring are being conducted by public health officials in California. There have now be...